CABG significantly reduced cardiovascular death rates compared to medical therapy alone in patients with left ventricular dysfunction.
Does medical therapy plus CABG reduce death from any cause in patients with left ventricular dysfunction?
In patients with left ventricular dysfunction, adding CABG to medical therapy did not significantly reduce all-cause mortality, but it did lower rates of cardiovascular death and the composite of death or cardiovascular hospitalization.
Absolute Event Rate: 0% vs 0%
In this randomized trial, there was no significant difference between medical therapy alone and medical therapy plus CABG with respect to the primary end point of death from any cause. Patients assigned to CABG, as compared with those assigned to medical therapy alone, had lower rates of death from cardiovascular causes and of death from any cause or hospitalization for cardiovascular causes. (Funded by the National Heart, Lung, and Blood Institute and Abbott Laboratories; STICH ClinicalTrials.gov number, NCT00023595.).
Velazquez et al. (Mon,) reported a other. CABG significantly reduced cardiovascular death rates compared to medical therapy alone in patients with left ventricular dysfunction.